Open in Screener

EVH

Evolent Health Inc

Feb 24 • 04:00PM ET

2.56

-0.21 -7.58 %

Healthcare • Health Information Services • USA • NYSE

Feb 24, 11:54 PMEvolent guides to ~30% 2026 revenue growth but trims near‑term EBITDA outlook on reserves and ACA exchange contraction

Peers: UNH HUM CI CNC MOH HQY AMED UHS ACHC OPCH

| Held by: VTI IWM VB VXF VBK IWN VTWO VFVA FNDA SCHA

Index	RUT	P/E	-	EPS (ttm)	-1.57	Insider Own	8.22%	Shs Outstand	111.59M	Perf Week	-5.88%
Market Cap	285.70M	Forward P/E	5.44	EPS next Y	0.47	Insider Trans	0.11%	Shs Float	102.42M	Perf Month	-35.03%
Enterprise Value	1.23B	PEG	0.05	EPS next Q	-0.02	Inst Own	104.28%	Short Float	18.75%	Perf Quarter	-30.62%
Income	-180.88M	P/S	0.14	EPS this Y	74.43%	Inst Trans	-11.92%	Short Ratio	6.46	Perf Half Y	-73.33%
Sales	2.05B	P/B	0.34	EPS next Y	200.01%	ROA	-5.17%	Short Interest	19.20M	Perf YTD	-36.00%
Book/sh	7.55	P/C	2.04	EPS next 5Y	99.10%	ROE	-13.63%	52W High	12.06 -78.78%	Perf Year	-74.85%
Cash/sh	1.26	P/FCF	-	EPS past 3/5Y	-31.56% 25.98%	ROIC	-9.51%	52W Low	2.56 0.20%	Perf 3Y	-92.67%
Dividend Est.	0.11 (4.13%)	EV/EBITDA	11.00	Sales past 3/5Y	41.18% 24.73%	Gross Margin	13.51%	Volatility	5.81% 6.67%	Perf 5Y	-87.69%
Dividend TTM	-	EV/Sales	0.60	EPS Y/Y TTM	-71.92%	Oper. Margin	0.22%	ATR (14)	0.19	Perf 10Y	-70.30%
Dividend Ex-Date	-	Quick Ratio	1.33	Sales Y/Y TTM	-16.65%	Profit Margin	-8.81%	RSI (14)	25.23	Recom	1.27
Dividend Gr. 3/5Y	- -	Current Ratio	1.33	EPS Q/Q	13.17%	SMA20	-12.00%	Beta	0.27	Target Price	7.73
Payout	-	Debt/Eq	1.29	Sales Q/Q	-22.83%	SMA50	-28.22%	Rel Volume	1.72	Prev Close	2.77
Employees	4500	LT Debt/Eq	1.26	Earnings	Feb 24 AMC	SMA200	-63.86%	Avg Volume	2.97M	Price	2.56
IPO	Jun 05, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	56.56% 0.01%	Trades		Volume	5,127,554	Change	-7.58%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Nov-13-25	Upgrade	Stephens	Equal-Weight → Overweight	$7
Nov-13-25	Initiated	BMO Capital Markets	Outperform	$7
Jan-10-25	Initiated	Needham	Buy	$15
Dec-03-24	Reiterated	BTIG Research	Buy	$36 → $29
Nov-08-24	Downgrade	Stephens	Overweight → Equal-Weight	$38 → $16
Oct-11-24	Initiated	KeyBanc Capital Markets	Overweight	$35
Aug-09-24	Upgrade	Truist	Hold → Buy	$28 → $33
Apr-22-24	Initiated	Citigroup	Buy	$40
Mar-01-24	Initiated	Oppenheimer	Outperform	$45
Jan-03-24	Initiated	Barclays	Overweight	$39
Dec-06-23	Initiated	JMP Securities	Mkt Outperform	$37
Oct-16-23	Initiated	UBS	Buy	$46
Apr-12-23	Initiated	Stephens	Overweight	$40
Nov-01-22	Initiated	Truist	Hold	$33
Jul-29-22	Initiated	RBC Capital Mkts	Outperform	$40
Mar-30-22	Initiated	Guggenheim	Buy	$43
Nov-18-21	Upgrade	JP Morgan	Neutral → Overweight	$26 → $37
Apr-29-21	Resumed	JP Morgan	Neutral	$23
Jan-07-21	Initiated	BTIG Research	Buy	$20

Show Previous Ratings

Today 02:07AM	Evolent Health Q4 Earnings Call Highlights (MarketBeat)
12:01AM	Evolent Health Inc (EVH) Q4 2025 Earnings Call Highlights: Strong Oncology Growth and Strategic ... (GuruFocus.com)
Feb-24-26 10:30PM	Compared to Estimates, Evolent Health (EVH) Q4 Earnings: A Look at Key Metrics (Zacks) -7.58%
09:55PM	Evolent Health (EVH) Q4 Earnings Top Estimates (Zacks)
04:51PM	Evolent Health: Q4 Earnings Snapshot (Associated Press Finance)
04:46PM	Loading…
04:46PM	Evolent Health (NYSE:EVH) Reports Q4 CY2025 In Line With Expectations (StockStory)
Feb-22-26 10:10PM	Evolent Health (EVH) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
Feb-11-26 11:36PM	3 Value Stocks We Find Risky (StockStory)
Feb-09-26 09:14AM	Evolent Health (EVH): From ACA Headwinds to Specialty Care Expansion (Insider Monkey)
Feb-05-26 07:45AM	Omnicell (OMCL) Q4 Earnings Lag Estimates (Zacks) -5.56%
Feb-04-26 11:02AM	Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026 (PR Newswire)
Jan-02-26 04:15PM	Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 (PR Newswire)
Dec-23-25 08:48AM	Is the Options Market Predicting a Spike in Evolent Health Stock? (Zacks)
Dec-22-25 09:53AM	Evolent Health (EVH) Sells ACO Unit, Strengthens Balance Sheet (Insider Monkey)
Dec-15-25 11:11PM	Evolent Health (EVH) Downgraded by Canaccord Amid Increased Near-Term Uncertainty and Ambiguity in Medicare/Medicaid Membership (Insider Monkey)
01:27AM	Loading…
Nov-20-25 01:27AM	Evolent Health, American Oncology Network Partner to Streamline Cancer Care (Insider Monkey)
Nov-19-25 04:05PM	Why Evolent Health (EVH) Shares Are Sliding Today (StockStory) -11.50%
Nov-17-25 11:03PM	3 Reasons to Sell EVH and 1 Stock to Buy Instead (StockStory) -7.42%
Nov-13-25 10:32PM	Healthcare Technology for Providers Stocks Q3 In Review: Evolent Health (NYSE:EVH) Vs Peers (StockStory) -6.52%
12:36AM	The Top 5 Analyst Questions From Evolent Health's Q3 Earnings Call (StockStory)
Nov-12-25 03:20PM	Why Evolent Health (EVH) Shares Are Sliding Today (StockStory) -11.71%
Nov-07-25 06:30PM	EVH Q3 Deep Dive: Contract Wins and Industry Uncertainty Shape Outlook (StockStory) -17.33%
12:11AM	Evolent Health Inc (EVH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market ... (GuruFocus.com)
Nov-06-25 08:30PM	Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics (Zacks) -5.51%
06:35PM	Evolent Health (EVH) Misses Q3 Earnings Estimates (Zacks)
05:34PM	Evolent Health: Q3 Earnings Snapshot (Associated Press Finance)
05:17PM	Evolent Health (NYSE:EVH) Beats Q3 Sales Expectations, Stock Jumps 14.8% (StockStory)
04:12PM	Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden (PR Newswire)
04:10PM	Evolent Announces Third Quarter 2025 Results (PR Newswire)
Nov-04-25 10:16PM	Evolent Health (EVH) Reports Earnings Tomorrow: What To Expect (StockStory)
05:35PM	Loading…
Nov-03-25 05:35PM	Inspire Medical Systems (INSP) Tops Q3 Earnings and Revenue Estimates (Zacks)
Oct-09-25 08:30AM	Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025 (PR Newswire)
Sep-26-25 12:05AM	3 Reasons EVH is Risky and 1 Stock to Buy Instead (StockStory)
Sep-25-25 12:41PM	Why Evolent Health (EVH) Shares Are Sliding Today (StockStory) -7.18%
Sep-24-25 01:38PM	Privia Health Acquires Evolent's ACO Business To Boost Value-Based Care (Benzinga) +14.54%
12:00PM	Evolent Health (EVH) Stock Trades Up, Here Is Why (StockStory)
05:14AM	Privia acquires Evolents value-based primary care unit for $100M (Healthcare Dive)
Sep-23-25 04:10PM	Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners (PR Newswire)
Sep-17-25 12:12PM	CVS vs. EVH: Which Value-Based Care Stock Deserves Investor Attention? (Zacks)
Sep-10-25 11:31PM	Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Evolent Health (NYSE:EVH) (StockStory) -8.01%
Aug-19-25 07:00AM	Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock (PR Newswire)
Aug-18-25 04:05PM	Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock (PR Newswire)
Aug-14-25 01:42AM	5 Insightful Analyst Questions From Evolent Health's Q2 Earnings Call (StockStory)
Aug-11-25 09:38AM	EVH Q2 Deep Dive: Revenue Falls Short, Guidance Cut as Margin Initiatives Continue (StockStory)
Aug-08-25 12:21PM	Why Evolent Health (EVH) Stock Is Nosediving (StockStory) -7.12%
05:10AM	Evolent Health (NYSE:EVH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops (StockStory)
03:41AM	Evolent Health Inc (EVH) Q2 2025 Earnings Call Highlights: Strong Partnerships and Revenue ... (GuruFocus.com)
Aug-07-25 08:00PM	Evolent Health (EVH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
06:15PM	Evolent Health (EVH) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:16PM	Evolent Health: Q2 Earnings Snapshot (Associated Press Finance)
04:10PM	Evolent Announces Second Quarter 2025 Results (PR Newswire)
Aug-05-25 11:16PM	Evolent Health (EVH) Q2 Earnings Report Preview: What To Look For (StockStory)
Jul-31-25 05:40PM	iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
10:00AM	Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline (Zacks)
Jul-29-25 08:55AM	NYSE Content Advisory: Pre-market update + Wall Street anticipates Fed's next move (PR Newswire)
Jul-23-25 10:03AM	Ashley Snyder Joins Medical Home Network as Chief Development Officer to Lead Partnership Efforts (PR Newswire)
Jul-18-25 03:10PM	Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know (StockStory) -15.44%
Jul-14-25 08:00AM	Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 (PR Newswire)
Jul-09-25 08:00AM	Evolent announces key appointments to leadership team (PR Newswire)
Jul-07-25 10:18AM	The Top 5 Analyst Questions From Evolent Health's Q1 Earnings Call (StockStory)
Jun-30-25 12:02AM	3 Reasons to Avoid EVH and 1 Stock to Buy Instead (StockStory)
Jun-23-25 08:35AM	Evolent Health (EVH) Stock Jumps 6.9%: Will It Continue to Soar? (Zacks) +13.51%
Jun-20-25 06:30AM	Evolent reiterates Q2 and full year guidance for Adjusted EBITDA (PR Newswire) +6.94%
Jun-10-25 07:48AM	EVH Q1 Earnings Call: Oncology Navigation Launch and AI Automation Drive Strategic Focus (StockStory) +5.78%
May-27-25 02:28PM	Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know (StockStory) +6.80%
May-21-25 11:34PM	Reflecting On Healthcare Technology for Providers Stocks' Q1 Earnings: Evolent Health (NYSE:EVH) (StockStory) -8.78% -8.00%
May-09-25 02:00PM	Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks) -16.05%
08:13AM	Q1 2025 Evolent Health Inc Earnings Call (Thomson Reuters StreetEvents)
03:46AM	Evolent Health Inc (EVH) Q1 2025 Earnings Call Highlights: Strong Start with New Agreements and ... (GuruFocus.com)
May-08-25 06:35PM	Evolent Health (EVH) Q1 Earnings Lag Estimates (Zacks)
05:33PM	Evolent Health: Q1 Earnings Snapshot (Associated Press Finance)
04:10PM	Evolent Announces First Quarter 2025 Results (PR Newswire)
May-07-25 05:20PM	Evolent Health Q1 2025 Earnings Preview (Seeking Alpha)
10:19AM	What to Expect from Evolent Health Inc (EVH) Q1 2025 Earnings (GuruFocus.com)
09:55AM	Wall Street Analysts Believe Evolent Health (EVH) Could Rally 53.33%: Here's is How to Trade (Zacks)
May-05-25 12:37AM	1 Unprofitable Stock Worth Investigating and 2 to Question (StockStory)
Apr-29-25 05:06AM	Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks (StockStory) +5.35%
Apr-28-25 05:04AM	Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks (StockStory)
Apr-22-25 06:30AM	Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors (PR Newswire)
Apr-15-25 09:00AM	Evolent program achieves 20% reduction in use of low-value oncology regimens (PR Newswire) -5.11%
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha)
12:30AM	Embark Small Cap Equity Fund Q4 2024 Commentary (Seeking Alpha)
Apr-10-25 05:00PM	Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025 (PR Newswire)
Apr-01-25 10:05AM	Evolent Health, Inc. (EVH): Among Stocks Insiders Were Buying In Q1 2025 (Insider Monkey)
Mar-28-25 04:51PM	Is Evolent Health, Inc. (EVH) About to Explode? (Insider Monkey)
Mar-25-25 10:45AM	Allspring Small Company Growth Fund Q4 2024 Commentary (SeekingAlpha)
07:39AM	Here's What Challenged Evolent Health (EVH) Despite Strong Revenue Growth (InsiderMonkey)
Mar-21-25 04:30AM	Lazard US Small Cap Equity Select Portfolio Q4 2024 Commentary (SeekingAlpha)
Mar-20-25 12:00PM	Lazard US Equity Concentrated Portfolio Q4 2024 Commentary (SeekingAlpha)
Mar-18-25 08:17AM	Evolent Health (EVH): Among Stocks Insiders Are Buying In March (Insider Monkey)
Mar-14-25 05:02AM	Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR) (StockStory)
Mar-11-25 05:30AM	Define Ventures Appoints Carolyn Magill as Venture Partner (PR Newswire)
Mar-07-25 04:00AM	3 Reasons to Sell EVH and 1 Stock to Buy Instead (StockStory)
Feb-21-25 07:15AM	Evolent Health (EVH) Q4 2024 Earnings Call Transcript (Motley Fool)
02:16AM	Evolent Health Inc (EVH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Oncology ... (GuruFocus.com)
Feb-20-25 06:00PM	Evolent Health (EVH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:43PM	Evolent Health (NYSE:EVH) Misses Q4 Sales Targets (StockStory)
05:40PM	Evolent Health (EVH) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:41PM	Evolent Health: Q4 Earnings Snapshot (Associated Press Finance)
04:10PM	Evolent Announces Fourth Quarter and Full Year 2024 Results (PR Newswire)

Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Springstubb Brendan B	Director	Nov 18 '25	Buy	3.82	10,000	38,199	58,821	Nov 19 04:23 PM
Holder Diane	Director	Mar 06 '25	Buy	9.33	2,735	25,518	70,584	Mar 10 08:20 AM
McCarthy Daniel Joseph	PRESIDENT	Mar 06 '25	Buy	9.01	11,040	99,470	389,004	Mar 10 08:18 AM
Jelinek Richard M	Director	Mar 07 '25	Buy	9.12	30,000	273,750	15,000	Mar 10 08:16 AM
GRUA PETER J	Director	Mar 06 '25	Buy	9.01	11,040	99,470	18,749	Mar 10 08:13 AM
Blackley Seth	Chief Executive Officer	Mar 06 '25	Buy	9.01	55,225	497,577	762,217	Mar 10 08:11 AM
Springstubb Brendan B	Director	Mar 07 '25	Buy	9.27	15,000	139,050	26,842	Mar 10 08:10 AM
Glass Russell Monroe	Director	Mar 06 '25	Buy	9.27	5,400	50,058	14,272	Mar 10 08:07 AM
KECK KIM	Director	Mar 07 '25	Buy	9.44	10,540	99,498	39,522	Mar 10 08:04 AM
Barbarosh Craig A.	Director	Mar 06 '25	Buy	8.81	2,000	17,620	31,956	Mar 10 08:02 AM
Springstubb Brendan B	Director	Mar 04 '25	Buy	8.75	5,000	43,750	11,842	Mar 05 05:28 PM

Open in Screener

HSIC

Henry Schein Inc

Feb 24 • 04:00PM ET

83.35

+2.78 3.45 %

Healthcare • Medical Distribution • USA • NASD

Peers: PDCO XRAY NVST ALGN ZBH BIO BDX STE SNN MCK

| Held by: VTI VOO RSP VB VBR IVV SPY XLV IWR DFAS

Index	S&P 500	P/E	25.51	EPS (ttm)	3.27	Insider Own	14.87%	Shs Outstand	115.77M	Perf Week	7.95%
Market Cap	9.81B	Forward P/E	14.07	EPS next Y	5.92	Insider Trans	0.00%	Shs Float	100.21M	Perf Month	7.95%
Enterprise Value	14.64B	PEG	1.52	EPS next Q	1.22	Inst Own	91.00%	Short Float	5.16%	Perf Quarter	17.10%
Income	398.00M	P/S	0.74	EPS this Y	7.16%	Inst Trans	-5.85%	Short Ratio	3.98	Perf Half Y	19.76%
Sales	13.18B	P/B	2.97	EPS next Y	11.23%	ROA	3.71%	Short Interest	5.17M	Perf YTD	10.28%
Book/sh	28.03	P/C	62.90	EPS next 5Y	9.26%	ROE	11.99%	52W High	82.80 0.66%	Perf Year	7.35%
Cash/sh	1.33	P/FCF	17.12	EPS past 3/5Y	-5.75% 3.12%	ROIC	6.85%	52W Low	60.56 37.63%	Perf 3Y	3.13%
Dividend Est.	-	EV/EBITDA	13.56	Sales past 3/5Y	1.40% 5.43%	Gross Margin	29.14%	Volatility	4.26% 3.30%	Perf 5Y	28.21%
Dividend TTM	-	EV/Sales	1.11	EPS Y/Y TTM	7.11%	Oper. Margin	5.83%	ATR (14)	2.82	Perf 10Y	26.80%
Dividend Ex-Date	-	Quick Ratio	0.76	Sales Y/Y TTM	4.03%	Profit Margin	3.02%	RSI (14)	64.36	Recom	2.47
Dividend Gr. 3/5Y	- -	Current Ratio	1.38	EPS Q/Q	13.61%	SMA20	7.05%	Beta	0.88	Target Price	87.92
Payout	0.00%	Debt/Eq	1.06	Sales Q/Q	7.71%	SMA50	7.54%	Rel Volume	3.67	Prev Close	80.57
Employees	25000	LT Debt/Eq	0.79	Earnings	Feb 24 BMO	SMA200	16.54%	Avg Volume	1.30M	Price	83.35
IPO	Nov 03, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.88% 2.69%	Trades		Volume	4,576,787	Change	3.45%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-23-26	Upgrade	Robert W. Baird	Neutral → Outperform	$100
Dec-09-25	Initiated	Barclays	Overweight	$86
Aug-26-25	Upgrade	Evercore ISI	In-line → Outperform	$83
Jul-25-25	Downgrade	Stifel	Buy → Hold	$75
Jul-14-25	Downgrade	Robert W. Baird	Outperform → Neutral	$72
Feb-14-25	Initiated	Wells Fargo	Equal Weight	$80
Jan-06-25	Upgrade	BofA Securities	Underperform → Buy	$69 → $84
Dec-04-24	Initiated	Mizuho	Neutral	$75
Jul-22-24	Upgrade	Robert W. Baird	Neutral → Outperform	$81 → $92
Feb-26-24	Initiated	Leerink Partners	Market Perform	$78
Dec-12-23	Upgrade	JP Morgan	Neutral → Overweight	$71 → $82
Nov-10-23	Upgrade	Stifel	Hold → Buy	$70
Aug-08-22	Upgrade	UBS	Sell → Neutral	$80
Jul-21-22	Downgrade	Goldman	Buy → Neutral	$93 → $85
Jun-14-22	Downgrade	Robert W. Baird	Outperform → Neutral	$103 → $88
May-13-22	Resumed	Credit Suisse	Outperform	$100
Jan-31-22	Initiated	Morgan Stanley	Underweight	$67
Jan-07-22	Upgrade	Credit Suisse	Neutral → Outperform	$78 → $90
Oct-01-21	Resumed	Credit Suisse	Neutral	$78
Feb-08-21	Resumed	Piper Sandler	Overweight	$83

Show Previous Ratings

Feb-24-26 03:10PM	Henry Schein (HSIC) Stock Trades Up, Here Is Why (StockStory)
02:03PM	Henry Schein Inc (HSIC) Q4 2025 Earnings Call Highlights: Record Sales Growth and Strategic ... (GuruFocus.com)
01:55PM	Henry Schein Stock Hits 52-Week High - Here's Why (Benzinga)
12:32PM	Henry Schein, Inc. Q4 2025 Earnings Call Summary (Moby)
11:47AM	Henry Schein Q4 Earnings Call Highlights (MarketBeat)
11:10AM	Loading…
11:10AM	Stocks Rally as AI-Fueled Worries Ease (Barchart)
09:59AM	Stocks Rebound as Software Stocks Recover (Barchart)
09:30AM	Henry Schein (HSIC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:46AM	HSIC Q4 Earnings & Revenues Beat Estimates, Margins Down (Zacks)
07:54AM	Henry Schein's (NASDAQ:HSIC) Q4 CY2025 Sales Beat Estimates (StockStory)
07:35AM	Henry Schein (HSIC) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
06:17AM	Henry Schein: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	Henry Schein Reports Fourth Quarter and Full Year 2025 Financial Results and Introduces 2026 Financial Guidance (Business Wire)
Feb-23-26 09:32AM	Alphabet, Nvidia upgraded: Wall Street's top analyst calls (The Fly)
Feb-22-26 10:09PM	Earnings To Watch: Henry Schein (HSIC) Reports Q4 Results Tomorrow (StockStory)
10:00AM	Loading…
Feb-19-26 10:00AM	Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
06:30AM	Henry Schein One Launches Image Verify, Another Transformative Step Towards Achieving the Cleanest Claims in the Industry (Business Wire)
Feb-17-26 10:00AM	Henry Schein (HSIC) Earnings Expected to Grow: Should You Buy? (Zacks)
09:19AM	Henry Schein Q4 Earnings Preview: What's in Store for the Stock? (Zacks)
06:30AM	Henry Schein One Connects Align Technologys iTero Scanners to Dentrix, Dentrix Ascend, and Dentally, Advancing a More Connected Global Standard of Care (Business Wire)
Feb-16-26 10:39AM	Henry Schein Stock: Analyst Estimates & Ratings (Barchart)
Feb-06-26 06:30AM	A Legacy of Brighter Smiles: Celebrating 24 Years of the Give Kids A Smile Program (Business Wire)
Jan-22-26 06:30AM	Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET (Business Wire)
Jan-20-26 09:47AM	Here's What to Expect From Henry Schein's Next Earnings Report (Barchart)
Jan-15-26 10:00AM	Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer (Business Wire)
Jan-14-26 11:06PM	3 Reasons to Sell HSIC and 1 Stock to Buy Instead (StockStory)
01:27PM	JPM26: Henry Schein focuses on high-margin, high-growth business as new CEO announced (Medical Device Network)
Jan-13-26 09:40AM	Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term (Zacks)
Jan-12-26 11:15AM	Equity Indexes Recover Early Losses as Precious Metals Reach New Record Highs (Barchart)
09:57AM	Stocks Retreat on Concerns Over Fed Independence (Barchart)
07:00AM	Loading…
07:00AM	Henry Schein Names Frederick M. Lowery as Chief Executive Officer (Business Wire)
Jan-06-26 11:40AM	HSIC or SAUHY: Which Is the Better Value Stock Right Now? (Zacks)
Jan-05-26 12:37AM	New Henry Schein CEO expected by mid-January as Bergman extends tenure (MedTech Dive)
Dec-29-25 06:30AM	Henry Schein to Participate in the J.P. Morgan Conference in January (Business Wire)
Dec-26-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-23-25 04:05PM	Henry Schein Provides Update on CEO Search Process (Business Wire)
Dec-18-25 07:54AM	How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks? (Barchart)
Dec-09-25 04:00PM	Why Henry Schein (HSIC) Stock Is Up Today (StockStory)
02:37PM	Henry Schein, Inc. (HSIC): A Bull Case Theory (Insider Monkey)
Dec-04-25 11:30AM	Why Is Henry Schein (HSIC) Up 1.2% Since Last Earnings Report? (Zacks)
Dec-03-25 10:31PM	Q3 Rundown: Henry Schein (NASDAQ:HSIC) Vs Other Dental Equipment & Technology Stocks (StockStory)
Dec-02-25 08:25AM	HSIC Stock Benefits From Expanded Partnership With vVARDIS (Zacks)
Dec-01-25 04:34PM	Henry Schein Expands Partnership with vVARDIS (Business Wire)
07:52AM	HSIC Stock Set to Benefit From Henry Schein One's Workflow Launch (Zacks)
Nov-25-25 06:30AM	Henry Schein One Unveils Industry-first Natively Embedded Voice Workflow at 2025 Greater New York Dental Meeting (Business Wire)
Nov-13-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
06:30AM	Henry Schein to Participate in Upcoming Investor Conference in December (Business Wire)
Nov-12-25 07:00AM	Sick of hearing about the AI trade? BofA offers 16 hot stock picks that go far beyond tech. (MarketWatch)
Nov-11-25 08:26AM	BofA lists 16 stock opportunities away from AI (Investing.com)
Nov-07-25 09:50AM	Here's Why Henry Schein (HSIC) is a Strong Momentum Stock (Zacks)
Nov-06-25 10:21PM	Jim Cramer on Henry Schein: "I Think It's a Good Stock" (Insider Monkey)
09:45AM	Here's Why Henry Schein (HSIC) is a Strong Growth Stock (Zacks)
08:00AM	November Is The Best Month And 5 Stocks Are Already On Fire (Investor's Business Daily)
Nov-04-25 04:00PM	Henry Schein Inc (HSIC) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amid Margin Pressures (GuruFocus.com) +10.78%
09:30AM	Here's What Key Metrics Tell Us About Henry Schein (HSIC) Q3 Earnings (Zacks)
08:54AM	HSIC Stock Jumps on Q3 Earnings and Revenue Beat, '25 Outlook Up (Zacks)
07:10AM	Henry Schein (HSIC) Q3 Earnings and Revenues Beat Estimates (Zacks)
06:36AM	Henry Schein's (NASDAQ:HSIC) Q3: Beats On Revenue, Stock Soars (StockStory)
06:10AM	Henry Schein: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Henry Schein Reports Record Third Quarter 2025 Financial Results and Raises Full Year Non-GAAP EPS Guidance (Business Wire)
Nov-03-25 06:30AM	Henry Schein One and AWS Collaborate to Transform Global Dentistry with Generative AI (Business Wire)
Nov-02-25 10:13PM	Henry Schein (HSIC) Q3 Earnings Report Preview: What To Look For (StockStory)
Oct-29-25 10:00AM	McKesson (MCK) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-28-25 10:00AM	Henry Schein (HSIC) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-23-25 08:07AM	Here's How Henry Schein Is Placed Ahead of Q3 Earnings (Zacks)
Oct-22-25 06:30AM	Henry Schein to Participate in Upcoming Investor Conferences in November (Business Wire)
Oct-21-25 07:28AM	Earnings Preview: What to Expect From Henry Scheins Report (Barchart)
06:30AM	Henry Schein to Webcast Third Quarter 2025 Conference Call on Tuesday, November 4, 2025, at 8:00 A.M. ET (Business Wire)
Oct-15-25 10:30AM	The Aspen Group Enhances Patient Experience with Planmeca Digital Imaging at Aspen Dental Locations Nationwide (PR Newswire)
Oct-08-25 12:02AM	3 Reasons to Avoid HSIC and 1 Stock to Buy Instead (StockStory)
Sep-25-25 01:07PM	Why Henry Schein (HSIC) Shares Are Trading Lower Today (StockStory)
07:22AM	Henry Schein Stock: Is HSIC Underperforming the Health Care Sector? (Barchart)
Sep-17-25 01:15PM	Henry Schein, Inc. (HSIC): A Bull Case Theory (Insider Monkey)
Sep-16-25 09:32AM	SOLV Strong Q2 Results Signal Momentum: Is the Stock Worth Buying Now? (Zacks)
Sep-11-25 08:31AM	BofA lists 13 SMID cap stocks that could rebound (Investing.com)
Sep-09-25 05:10PM	Henry Schein Announces $750 Million Share Repurchase Plan (Business Wire)
10:18AM	Henry Schein Medical Expands SolutionsHub with Colaborate (PR Newswire)
Aug-28-25 11:31PM	Dental Equipment & Technology Stocks Q2 Recap: Benchmarking Henry Schein (NASDAQ:HSIC) (StockStory)
Aug-22-25 06:30AM	Henry Schein to Participate in Upcoming Investor Conferences in September (Business Wire)
Aug-21-25 11:39AM	Henry Schein Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
Aug-19-25 06:30AM	Henry Schein's 28th Annual 'Back to School' Program Supports Students Worldwide (Business Wire)
Aug-13-25 12:15AM	The Top 5 Analyst Questions From Henry Schein's Q2 Earnings Call (StockStory)
12:07AM	HSIC Q2 Deep Dive: Margin Pressures Persist Despite Solid Revenue, New Initiatives Announced (StockStory)
Aug-05-25 12:41PM	Why Henry Schein (HSIC) Shares Are Falling Today (StockStory) -7.41%
10:16AM	Henry Schein's 2025 Outlook Hinges On Strong Second-Half Execution (Benzinga)
09:30AM	Henry Schein (HSIC) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
09:05AM	Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top (Zacks)
07:10AM	Henry Schein (HSIC) Q2 Earnings Lag Estimates (Zacks)
06:50AM	Henry Schein's (NASDAQ:HSIC) Q2 Earnings Results: Revenue In Line With Expectations (StockStory)
06:07AM	Henry Schein: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Henry Schein Reports Second Quarter 2025 Financial Results (Business Wire)
Aug-03-25 11:17PM	Henry Schein (HSIC) Reports Earnings Tomorrow: What To Expect (StockStory)
Jul-30-25 10:00AM	McKesson (MCK) Earnings Expected to Grow: Should You Buy? (Zacks)
06:30AM	Henry Schein One Launches Forms to Make Patient Check-In Easier and Faster (Business Wire)
Jul-29-25 10:00AM	Henry Schein (HSIC) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
08:07AM	Henry Schein to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
Jul-22-25 06:30AM	Henry Schein to Webcast Second Quarter 2025 Conference Call on Tuesday, August 5, 2025, at 8:00 a.m. ET (Business Wire)
Jul-21-25 04:07PM	ZimVie Doubles And Then Some On Its Second Takeover Deal (Investor's Business Daily)
Jul-16-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
06:02AM	Henry Schein's Quarterly Earnings Preview: What You Need to Know (Barchart)

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Siegel Walter	Officer	Nov 17 '25	Proposed Sale	71.30	4,176	297,749		Nov 17 10:29 AM
DANIEL WILLIAM K	Director	Aug 07 '25	Buy	67.08	10,000	670,800	10,000	Aug 11 04:26 PM
LASKAWY PHILIP A	Director	Mar 19 '25	Sale	71.04	2,604	184,999	24,805	Mar 20 04:28 PM
Connett Bradford C	CEO, NA Distribution Group	Mar 19 '25	Sale	71.15	4,036	287,161	62,688	Mar 20 04:19 PM
Connett Bradford C	Officer	Mar 19 '25	Proposed Sale	71.15	4,036	287,161		Mar 19 04:46 PM
LASKAWY PHILIP A	Director	Mar 19 '25	Proposed Sale	71.04	2,604	184,999		Mar 19 02:14 PM
KUEHN KURT P	Director	Mar 05 '25	Sale	71.55	2,787	199,396	15,687	Mar 06 04:31 PM
KUEHN KURT P	Director	Mar 05 '25	Proposed Sale	71.55	2,787	199,396		Mar 05 04:45 PM

EVH

Evolent Health Inc

HSIC

Henry Schein Inc

Upgrade your FINVIZ experience